CM
Castleark Management Portfolio holdings
AUM
$3.33B
1-Year Return
37.9%
This Quarter Return
+14.76%
1 Year Return
+37.9%
3 Year Return
+222.09%
5 Year Return
+481.09%
10 Year Return
+2,703.89%
AUM
$3.48B
AUM Growth
+$231M
(+7.1%)
Cap. Flow
-$39.9M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
17.4%
Holding
433
New
64
Increased
81
Reduced
104
Closed
64
Top Buys
| 1 |
Eli Lilly
LLY
|
$31.1M |
| 2 |
Centene
CNC
|
$18.3M |
| 3 |
KBR
KBR
|
$17.6M |
| 4 |
IQVIA
IQV
|
$17.4M |
| 5 |
AMED
Amedisys
AMED
|
$17.3M |
Top Sells
| 1 |
Charles Schwab
SCHW
|
$26M |
| 2 |
PVH
PVH
|
$18.3M |
| 3 |
Tapestry
TPR
|
$18.2M |
| 4 |
Integra LifeSciences
IART
|
$18.1M |
| 5 |
MasTec
MTZ
|
$17.7M |
Sector Composition
| 1 | Healthcare | 23.59% |
| 2 | Technology | 16.66% |
| 3 | Industrials | 12.24% |
| 4 | Consumer Discretionary | 11.63% |
| 5 | Financials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
CareDx
CDNA
$719M
| $6.01M | 0.17% |
+208,235
| New | +$6.01M |
|
177
Vericel Corp
VCEL
$1.73B
| $5.99M | 0.17% |
423,597
-296,988
| -41% | -$4.2M |
|
178
Chevron
CVX
$312B
| $5.95M | 0.17% |
48,695
| – | – |
|
179
Qiagen
QGEN
$10.3B
| $5.94M | 0.17% |
147,862
-12,462
| -8% | -$501K |
|
180
BP
BP
$87.2B
| $5.9M | 0.17% |
134,083
-66,840
| -33% | -$2.94M |
|
181
IAC Inc
IAC
$2.96B
| $5.87M | 0.17% |
151,636
-65,690
| -30% | -$2.54M |
|
182
Flowserve
FLS
$7.18B
| $5.81M | 0.17% |
+106,275
| New | +$5.81M |
|
183
Grand Canyon Education
LOPE
$5.67B
| $5.77M | 0.17% |
+51,180
| New | +$5.77M |
|
184
Neurocrine Biosciences
NBIX
$14.4B
| $5.74M | 0.16% |
46,665
+4,195
| +10% | +$516K |
|
|
WRD
185
DELISTED
WildHorse Resource Development
WRD
| $5.68M | 0.16% |
+240,135
| New | +$5.68M |
|
186
Viper Energy
VNOM
$6.33B
| $5.62M | 0.16% |
133,453
| – | – |
|
|
LOXO
187
DELISTED
Loxo Oncology, Inc
LOXO
| $5.54M | 0.16% |
32,445
-1,150
| -3% | -$196K |
|
188
Curtiss-Wright
CW
$17.9B
| $5.44M | 0.16% |
+39,600
| New | +$5.44M |
|
189
West Pharmaceutical
WST
$18B
| $5.4M | 0.16% |
+43,755
| New | +$5.4M |
|
190
Bio-Rad Laboratories Class A
BIO
$7.98B
| $5.32M | 0.15% |
16,980
-1,510
| -8% | -$473K |
|
191
NNN REIT
NNN
$8.1B
| $5.31M | 0.15% |
+118,560
| New | +$5.31M |
|
192
Surmodics
SRDX
$472M
| $5.3M | 0.15% |
+70,960
| New | +$5.3M |
|
|
PSXP
193
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $5.2M | 0.15% |
101,669
| – | – |
|
194
Vertex Pharmaceuticals
VRTX
$101B
| $5.17M | 0.15% |
26,830
| – | – |
|
195
Suncor Energy
SU
$48.3B
| $5.09M | 0.15% |
131,490
| – | – |
|
|
RDS.A
196
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $4.99M | 0.14% |
73,200
| – | – |
|
|
ESV
197
DELISTED
Ensco Rowan plc
ESV
| $4.91M | 0.14% |
145,408
| – | – |
|
198
Tactile Systems Technology
TCMD
$302M
| $4.89M | 0.14% |
+68,750
| New | +$4.89M |
|
199
Advanced Micro Devices
AMD
$248B
| $4.7M | 0.14% |
+152,250
| New | +$4.7M |
|
200
Equinor
EQNR
$59.8B
| $4.63M | 0.13% |
164,260
| – | – |
|